Top U.S. Growth Stocks

Top U.S. Growth Stocks

UPDATED Sep 25, 2023

What are the best U.S. Growth Stocks?

According to our Simply Wall St analysis these are the best U.S. growth companies. We look for companies with high forecasted growth and healthy balance sheets that can deliver sustained growth over the long term.

Our criteria to find Top Growth Companies

Growth

  • Companies with sustained revenue growth that outperforms the market are attractive to investors. These companies are most likely to appreciate in share price over time.

What do we look for?

  • Is the company forecast to have high earnings growth.

Healthy Balance Sheet

  • A healthy balance sheet is essential to drive growth opportunities and sustain the business.
  • Repayments on debt take precedence over other initiatives to improve shareholder returns, so investors want to make sure the company is comfortably positioned to cover its debts.

What do we look for?

  • Does the company have a manageable level of debt.
  • Is the company able to cover its interest repayments.

96 companies meet this criteria in the U.S. market

Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States.

Growth Criteria

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings: ZVRA is expected to become profitable in the next 3 years.

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE

See Full Stock Report

Rewards

  • Trading at 92.7% below our estimate of its fair value

  • Earnings are forecast to grow 70.37% per year

Risks

No risks detected for ZVRA from our risks checks.

View all Risks and Rewards

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

Growth Criteria

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings: SRPT is expected to become profitable in the next 3 years.

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE

See Full Stock Report

Rewards

  • Trading at 71.4% below our estimate of its fair value

  • Earnings are forecast to grow 64.69% per year

Risks

  • Shareholders have been diluted in the past year

View all Risks and Rewards

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases.

Growth Criteria

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings: ACAD is expected to become profitable in the next 3 years.

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE

See Full Stock Report

Rewards

  • Trading at 87.5% below our estimate of its fair value

  • Earnings are forecast to grow 61.26% per year

  • Earnings have grown 8.8% per year over the past 5 years

Risks

No risks detected for ACAD from our risks checks.

View all Risks and Rewards

Luckin Coffee Inc. offers retail services of freshly brewed drinks, and pre-made food and beverage items in the People's Republic of China.

Growth Criteria

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings: LKNC.Y's earnings are expected to grow significantly over the next 3 years.

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE

See Full Stock Report

Rewards

  • Trading at 64.4% below our estimate of its fair value

  • Earnings are forecast to grow 31.81% per year

  • Earnings grew by 167.3% over the past year

Risks

  • Shareholders have been diluted in the past year

View all Risks and Rewards

Atour Lifestyle Holdings Limited, through its subsidiaries, provides lifestyle brands around hotel offerings in the People’s Republic of China.

Growth Criteria

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings: ATAT's earnings are expected to grow significantly over the next 3 years.

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE

See Full Stock Report

Rewards

  • Trading at 30.7% below our estimate of its fair value

  • Earnings are forecast to grow 49.19% per year

  • Earnings grew by 103.4% over the past year

Risks

No risks detected for ATAT from our risks checks.

View all Risks and Rewards

FTC Solar, Inc. provides solar tracker systems, software, and engineering services in the United States and internationally.

Growth Criteria

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings: FTCI is expected to become profitable in the next 3 years.

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE

See Full Stock Report

Rewards

  • Trading at 94.7% below our estimate of its fair value

  • Earnings are forecast to grow 73.95% per year

Risks

  • Shareholders have been diluted in the past year

  • Significant insider selling over the past 3 months

  • Volatile share price over the past 3 months

  • Has less than 1 year of cash runway

View all Risks and Rewards

CrowdStrike Holdings, Inc. provides cloud-delivered protection across endpoints and cloud workloads, identity, and data.

Growth Criteria

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings: CRWD is expected to become profitable in the next 3 years.

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE

See Full Stock Report

Rewards

  • Trading at 32.7% below our estimate of its fair value

  • Earnings are forecast to grow 52.71% per year

Risks

  • Shareholders have been diluted in the past year

  • Significant insider selling over the past 3 months

View all Risks and Rewards

Valaris Limited provides offshore contract drilling services to the international oil and gas industry.

Growth Criteria

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings: VAL's earnings are expected to grow significantly over the next 3 years.

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE

See Full Stock Report

Rewards

  • Trading at 85.3% below our estimate of its fair value

  • Earnings are forecast to grow 84.1% per year

Risks

  • Significant insider selling over the past 3 months

View all Risks and Rewards
Page 1 of 12